Articles from AIVITA Biomedical, Inc.

AIVITA Biomedical, Inc., a biotechnology company developing personalized vaccines for the prevention of infectious disease and treatment of cancer, today announced that it has been named a 2026 Prix Galien USA nominee in the “Best Startup” category.

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, is pleased to announce the execution of a licensing agreement with LevEllis, a global skincare retailer, for the worldwide exclusive marketing and distribution rights to AIVITA’s proprietary skincare formulations. Formerly sold as Root of Skin™, AIVITA’s skincare products generated strong market testing metrics amongst licensed clinical dermatologists and set records for consecutive sell-outs on QVC Japan.